Global TIL Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Global TIL Therapy Market is Segmented By Therapy Type (Autologous TIL Therapy, Allogeneic TIL Therapy), By Cancer Type (Melanom, Cervical Cancer, Breast Cancer, Lung Cancer, Renal Cell Carcinoma, Others), By End-User (Hospitals, Cancer Research Institutes, Specialty Oncology Clinics, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Global TIL Therapy Market
The major players operating in the Global TIL Therapy Market include Lytix Biopharma, Phio Pharmaceuticals, Bristol-Myers Squibb, Incyte Corporation, Kite Pharma, Adaptimmune Therapeutics, Medigene AG, Takeda Pharmaceutical Company, Allogene Therapeutics, Prometheus Laboratories, Century Therapeutics, Arcellx, Immatics, Lyell Immunopharma and CAR-T (Shanghai) Cell Biotechnology.
Global TIL Therapy Market Leaders
- Iovance Biotherapeutics
- Instil Bio
- Obsidian Therapeutics
- Cellectis
- Cellular Biomedicine Group
Global TIL Therapy Market - Competitive Rivalry, 2023
Global TIL Therapy Market
(Dominated by major players)
(Highly competitive with lots of players.)